Assessment of personality in psychosomatic medicine: Current concepts

Advances in Psychosomatic Medicine

Volumn 32, Issue , 2012, Pages 133-159

  Cosci, Fiammetta ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE BEHAVIOR; CHARACTER; EMOTIONAL DISORDER; HEALTH BEHAVIOR; HUMAN; ILLNESS BEHAVIOR; PERSONALITY DISORDER; PERSONALITY TEST; PSYCHOLOGIC TEST; PSYCHOLOGICAL ASPECT; PSYCHOSOMATIC DISORDER; REVIEW; RISK FACTOR; SELF CARE; TEMPERAMENT; TYPE A BEHAVIOR;

ADAPTATION, PSYCHOLOGICAL; AFFECTIVE SYMPTOMS; CHARACTER; HEALTH BEHAVIOR; HUMANS; ILLNESS BEHAVIOR; INTERVIEW, PSYCHOLOGICAL; PERSONALITY ASSESSMENT; PERSONALITY DISORDERS; PSYCHOPHYSIOLOGIC DISORDERS; RISK FACTORS; SELF CARE; TEMPERAMENT; TYPE A PERSONALITY;

EID: 84856001818     PISSN: 00653268     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000330014-27     Document Type: Article

References (172)

1. Fava GA, Sonino N: The clinical domains of psychosomatics medicine. J Clin Psychiatry 2005;66: 849-858.
2. Engel GL: The need for a new medical model: a challenge for biomedicine. Science 1977;196: 129-136.
3. Taylor GJ, Bagby RM, Parker JDA: Disorders of affect regulation: Alexithymia in medical and psychiatric illness. Cambridge, Cambridge University Press, 1997.
4. Friedman M, Rosenman RH: Type A Behavior and Your Heart. New York, Knopf, 1974.
5. Porcelli P: Psychosomatic medicine and the Rorschach test. Madrid, Psimatica, 2004.
6. Sifneos PE: Clinical observations on some patients suffering from a variety of psychosomatic diseases. Acta Med Psychosom 1967;7: 1-10.
7. Nemiah JC, Freyberger H, Sifneos PE: Alexithymia: A view of the psychosomatic process; in Hill OW (eds): Modern trends in psychosomatic research. London, Buttersworth, 1976, vol 3, pp 430-439.
8. Lane RD, Sechrest L, Riedel R, Shapiro DE, Kaszniak AW: Pervasive emotion recognition deficit common to alexithymia and the repressive coping style. Psychosom Med 2000;62: 492-501.
9. Vermeulen N, Luminet O, Corneille O: Alexithymia and the automatic processing of affective information: evidence from the affective priming paradigm. Cogn Emot 2006;20: 64-91.
10. Mantani T, Okamoto Y, Shirao N, Okada G, Yamawaki S: Reduced activation of posterior cingulated cortex during imagery in subjects with high degrees of alexithymia: a functional magnetic resonance imaging study. Biol Psychiatry 2005;57: 982-990.
11. Taylor GJ: Affects, trauma, and mechanisms of symptom formation: a tribute to John C. Nemiah, MD (1918-2009). Psychother Psychosom 2010;79: 339-349.
12. Bagby RM, Taylor GJ, Parker JD, Dickens SE: The development of the Toronto Structured Interview for Alexithymia: item selection, factor structure, reliability and concurrent validity. Psychother Psychosom 2006;75: 25-39.
13. Lumley MA, Stettner L, Wehmer F: How are alexithymia and physical illness linked? A review and critique of pathways. J Psychosom Res 1996;41: 505-518.
14. Lumley MA, Neely LC, Burger AJ: The Assessment of Alexithymia in Medical Settings: Implications for Understanding and Treating Health Problems. J Pers Assess 2007;89: 230-246.
15. Ogrodniczuk JS, Piper WE, Joyce AS, Abbass AA: Alexithymia and treatment preferences among psychiatric outpatients. Psychother Psychosom 2009;78: 383-384.
16. Tulipani C, Morelli F, Spedicato MR, Maiello E, Todarello O, Porcelli P: Alexithymia and cancer pain: the effect of psychological intervention. Psychother Psychosom 2010;79: 156-163.
17. Topciu RA, Zhao X, Tang W, Heisel MJ, Talbot NL, Duberstein PR: Childhood sexual abuse and personality differentiating high and low alexithymia in a depressed population. Psychother Psychosom 2009;78: 385-387.
18. Bui E, Cailhol L, Puel J, Birmes P, Schmitt L: Effects of depressive symptoms, anxiety and alexithymia on physical functioning 6 months after percutaneous transluminal coronary angioplasty. Psychother Psychosom 2010;79: 59-60.
19. Kojima M, Hayano J, Suzuki S, Seno H, Kasuga H, Takahashi H, Toriyama T, Kawahara H, Furukawa TA: Depression, alexithymia and long-term mortality in chronic hemodialysis patients. Psychother Psychosom 2010;79: 303-311.
20. Sifneos PE: The prevalence of 'alexithymic' characteristics in psychosomatic patients. Psychother Psychosom 1973;22: 255-262.
21. Bagby RM, Parker JD, Taylor GJ: The Twenty-item Toronto Alexithymia Scale. I. Item selection and cross-validation of the factor structure. J Psychosom Res 1994;38: 23-32.
22. Haviland MG, Warren WL, Riggs ML, Nitch SR: Concurrent validity of two observer-rated alexithymia measures. Psychosomatics 2002;43: 472-477.
23. Krystal JH, Giller EL, Cicchetti DV: Assessment of alexithymia in posttraumatic stress disorder and somatic illness: introduction of a reliable measure. Psychosom Med 1986;48: 84-94.
24. Weinryb RM, Roessel RJ: Karolinska Psychodynamic Profile; KAPP. Acta Psychiatr Scand 1991;83: 1-23.
25. Fava GA, Freyberger HJ, Bech P, Christodoulou G, Sensky T, Theorell T, Wise TN: Diagnostic criteria for use in psychosomatic research. Psychother Psychosom 1995;63: 1-8.
26. Porcelli P, Sonino N: Psychological Factors Affecting Medical Conditions. A New Classification for DSM-V. Basel, Karger, 2007.
27. Wise TN: Diagnostic criteria for psychosomatic research are necessary for DSM V. Psychother Psychosom 2009;78: 330-332.
28. Fava GA, Sonino N: Psychosomatic assessment. Psychother Psychosom 2009;78: 333-341.
29. Rafanelli C, Roncuzzi R, Finos L, Tossani E, Tomba E, Mangelli L, Urbinati S, Pinelli G, Fava GA: Psychological assessment in cardiac rehabilitation. Psychother Psychosom 2003;72: 343-349.
30. Galeazzi GM, Ferrari S, Mackinnon A, Rigatelli M: Interrater reliability, prevalence, and relation to ICD-10 diagnoses of the Diagnostic Criteria for Psychosomatic Research in consultation-liaison psychiatry patients. Psychosomatics 2004;45: 386-393.
31. Porcelli P, De Carne M: Criterion-related validity of the Diagnostic Criteria for Psychosomatic Research for alexithymia in patients with functional gastrointestinal disorders. Psychother Psychosom 2001;70: 184-188.
32. Beresnevaite M, Taykor GJ, Bagby RM: Assessing alexithymia and type A behavior in coronary heart disease patients: a multimethod approach. Psychother Psychosom 2007;76: 186-192.
33. Grassi L, Sabato S, Rossi E, Biancosino B, Marmai L: Use of the Diagnostic Criteria for Psychosomatic Research in oncology. Psychother Psychosom 2005; 74: 100-107.
34. Porcelli P, De Carne M, Fava GA: Assessing somatization in functional gastrointestinal disorders: integration of different criteria. Psychother Psychosom 2000;69: 198-204.
35. Ferrari S, Galeazzi GM, Mackinnon A, Rigatelli M: Frequent attenders in primary care: impact of medical, psychiatric and psychosomatic diagnoses. Psychother Psychosom 2008;77: 306-314.
36. Porcelli P, Bellomo A, Quartesan R, Altamura M, Iuso S, Ciannameo I, Piselli M, Elisei S: Psychosocial functioning in consultation-liaison-psychiatry patients: influence of psychosomatic syndromes, psychopathology and somatization. Psychother Psychosom 2009;78: 352-358.
37. Fassino S, Abbate Daga G, Piero A, Delsedime N: Psychological factors affecting eating disorders; in Porcelli P, Sonino N (eds): Psychological Factors Affecting Medical Conditions. A New Classification for DSM-V. Basel, Karger, 2007, pp 142-168.
38. Haviland MG: The validity of the California Q-set alexithymia prototype. Psychosomatics 1998;39: 536-539.
39. Haviland MG, Reise SP: A California Q-set Alexithymia Prototype and its relationship to egocontrol and ego-resiliency. J Psychosom Res 1996; 41: 597-608.
40. Haviland MG, Warren WL, Riggs ML: An observer scale to measure alexithymia. Psychosomatics 2000;41: 385-392.
41. Haviland MG, Warren WL, Riggs ML, Gallacher M: Psychometric properties of the Observer Alexithymia Scale in a clinical sample. J Pers Assess 2001; 77: 176-186.
42. Mueller J, Alpers GW, Reim N: Dissociation of rated emotional valence and Stroop interference in observer-rated alexithymia. J Psychosom Res 2006; 61: 261-269.
43. Meganck R, Vanheule S, Desmet M, Inslegers R: The Observer Alexithymia Scale: A Reliable and Valid Alternative for Alexithymia Measurement? J Pers Assess 2010;92: 175-185.
44. Porcelli P, Mihura JL: Assessment of alexithymia with the Rorschach comprehensive system: The Rorschach Alexithymia Scale (RAS). J Pers Assess 2010;92: 128-136.
45. Clerici M, Albonetti S, Papa R, Penati G, Invernizzi G: Alexithymia and obesity. Psychother Psychosom 1992;57: 88-93.
46. Keltikangas-Jarvinen L: Concept of alexithymia. I. The prevalence of alexithymia in psychosomatic patients. Psychother Psychosom 1985;44: 132-138.
47. Acklin MW: Alexithymia, Somatization, and the Rorschach Response Process. Rorschachiana XVII. Bern, Hans Huber, 1992, pp 180-187.
48. Exner JE: The Rorschach: A Comprehensive System. Basic Foundations, ed 3. New York, Wiley, vol 1, 1993.
49. Acklin MW, Alexander G: Alexithymia and somatization: A Rorschach study of four psychosomatic groups. J Nerv Ment Dis 1988;176: 343-350.
50. Acklin MW, Bernat E: Depression, alexithymia, and pain prone disorder: A Rorschach study. J Pers Assess 1987;51: 462-479.
51. Clerici M, Albonetti S, Papa R, Penati G, Invernizzi G: Alexithymia and obesity. Study of the impaired symbolic function by the Rorschach test. Psychother Psychosom 1992;57: 88-93.
52. Parker JD, Taylor GJ, Bagby RM, Thomas S: Problems with measuring alexithymia. Psychosomatics 1991;32: 196-202.
53. Bagby RM, Parker JD, Taylor GJ: Reassessing the validity and reliability of the MMPI Alexithymia Scale. J Pers Assess 1991;56: 238-253.
54. Taylor GJ, Ryan D, Bagby RM: Toward the development of a new self-report alexithymia scale. Psychother Psychosom 1985;44: 191-199.
55. Bagby RM, Taylor GJ, Parker JD: Construct validity of the Toronto Alexithymia Scale. Psychother Psychosom 1988;50: 29-34.
56. Taylor GJ, Bagby RM, Parker JD: The 20-item Toronto Alexithymia Scale. IV. Reliability and factorial validity in different languages and cultures. J Psychosom Res 2003;55: 277-283.
57. Kooiman CG, Spinhoven P, Trijsburg RW: The assessment of alexithymia: a critical review of the literature and a psychometric study of the Toronto Alexithymia Scale-20. J Psychosom Res 2002;53: 1083-1090.
58. Gignac GE, Palmer BR, Stough C: A confirmatory factor analytic investigation of the TAS-20: Corroboration of a Five factor model and suggestions for improvement. J Pers Assess 2007;89: 247-257.
59. Bagby RM, Taylor GJ, Quilty LC, Parker JDA: Reexamining the factor structure of the 20-item Toronto Alexithymia Scale: Commentary on Gignac, Palmer, and Stough. J Pers Assess 2007;89: 258-264.
60. Lane RD, Quinlan DM, Schwartz GE, Walker PA, Zeitlin SB: The Levels of Emotional Awareness Scale: A cognitive-developmental measure of emotion. J Pers Assess 1990;55: 124-134.
61. Suslow T, Junghanns K, Donges US, Arolt V: Alexithymia and automatic processing of verbal and facial affect stimuli. Curr Psychol Cogn 2001;20: 297-324.
62. Bydlowski S, Corcos M, Jeammet P, Paterniti S, Berthoz S, Laurier C, Chambry J, Consoli SM: Emotion-processing deficits in eating disorders. Int J Eat Disord 2005;37: 321-329.
63. Subic-Wrana C, Bruder S, Thomas W, Lane RD, Kahana B: Emotional awareness deficits in inpatients of a psychosomatic ward: a comparison of two different measures of alexithymia. Psychosom Med 2005;67: 483-489.
64. Vorst HCM, Bermond B: Validity and reliability of the Bermond-Vorst Alexithymia Questionnaire. Pers Individ Diff 2001;30: 413-434.
65. Morera OF, Culhane SE, Watson PJ, Skewes MC: Assessing the reliability and validity of the Bermond- Vorst Alexithymia Questionnaire among U.S. Anglo and U.S. Hispanic samples. J Psychosom Res 2005; 58: 289-298.
66. Friedman M: Pathogenesis of Coronary Artery Disease. New York, McGraw-Hill, 1969.
67. Friedman M, Rosenman RH: Association of specific overt behavior pattern with blood and cardiovascular findings. JAMA 1959;169: 1286-1296.
68. Rosenman RH, Friedman M, Straus R, Wurm M, Kositchek R, Hahn W, Werthessen NT: A predictive study of coronary heart disease. JAMA 1964;189: 103-110.
69. Rosenman RH, Brand RJ, Jenkins CD, Friedman M, Straus R, Wurm W: Coronary heart disease in the Western Collaborative Group Study: final follow-up experience of 8 years. JAMA 1975;233: 872-877.
70. Jenkins CD, Rosenman RH, Zyzanski SJ: Prediction of clinical coronary heart disease by a test for the coronary prone behavior pattern. N Engl J Med 1974;290: 1271-1275.
71. Denollet J, Conraads VM, Brutsaert DL, De Clerck LS, Stevens WJ, Vrints CJ: Cytokines and immune activation in systolic heart failure: the role of Type D personality. Brain Behav Immun 2003;17: 304-309.
72. Rozanski A, Blumenthal JA, Kaplan J: Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999;99: 2192-2217.
73. Littman AB: Review of psychosomatic aspects of cardiovascular disease. Psychother Psychosom 1993;60: 148-167.
74. Hemingway H, Marmot M: Psychosocial factors in the etiology and prognosis of coronary heart disease. BMJ 1999;318: 1460-1467.
75. Sirri L, Fabbri S, Fava GA, Sonino N: New strategies in the assessment of psychological factors affecting medical conditions. J Person Assess 2007;89: 216-228.
76. Dembroski TM, MacDougall JM, Williams RB, Haney TL, Blumenthal JA: Components of Type A, hostility, and anger-in: relationship to angiographic findings. Psychosom Med 1985;47: 219-233.
77. Matthews KA, Glass DC, Rosenman RH, Bortner RW: Competitive drive, pattern A, and coronary heart disease: a further analysis of some data from the Western Collaborative Group Study. J Chronic Dis 1977;30: 489-498.
78. Dembroski TM, MacDougall JM, Costa PT Jr, Grandits GA: Components of hostility as predictors of sudden death and myocardial infarction in the Multiple Risk Factor Intervention Trial. Psychosom Med 1989;51: 514-522.
79. Diamond EL: The role of anger and hostility in essential hypertension and coronary heart disease. Psychol Bull 1982;92: 410-433.
80. Barefoot JC, Dahlstrom WG, Williams RB: Hostility, CHD incidence and total mortality: a 25-year follow- up study of 255 physicians. Psychosom Med 1983;45: 59-63.
81. Shekelle RB, Gale M, Ostfeld AM, Paul O: Hostility, risk of coronary heart disease, and mortality. Psychosom Med 1983;45: 109-114.
82. Haynes SG, Feinleib M, Kannel WB: The relationship of psychosocial factors to coronary heart disease in the Framingham Study. III. Eight-year incidence of coronary-heart disease. Am J Epidemiol 1980;111: 37-58.
83. Scherwitz L, Berton K, Leventhal H: Type A assessment and interaction in the behavior pattern interview. Psychosom Med 1977;39: 229-240.
84. Schucker B, Jacobs DR: Assessment of behavioral risk for coronary disease by voice characteristics. Psychosom Med 1977;39: 219-228.
85. Myrtek M, Greenlee MW: Psychophysiology of type A behavior pattern: a critical analysis. J Psychosom Res 1984;28: 455-466.
86. Rosenman RH: The interview method of assessment of the coronary prone behavior pattern; in Dembroski TM, Weiss SM, Shields JL, Haynes S, Feinleib M (eds): Coronary Prone Behavior. New York, Springer, 1978.
87. Sonino N, Navarrini C, Ruini C, Ottolini F, Paoletta A, Fallo F, Boscaro M, Fava GA: Persistent psychological distress in patients treated for endocrine disease. Psychother Psychosom 2004;73: 78-83.
88. Picardi A, Pasquini P, Abeni D, Fassone G, Mazzotti E, Fava GA: Psychosomatic assessment of skin diseases in clinical practice. Psychother Psychosom 2005;74: 315-322.
89. Friedman M: Type A Behavior: Its Diagnosis and Treatment. New York, Plenum Press, 1996.
90. Mangelli L, Semprini F, Sirri L, Fava GA, Sonnino N: Use of the Diagnostic Criteria for Psychosomatic Research (DCPR) in a community sample. Psychosomatics 2006;47: 143-146.
91. Jenkins CD, Rosenman RH, Friedman M: Development of an objective psychological test for the determination of the coronary prone behavior pattern in employed men. J Chron Dis 1967;20: 371-379.
92. Zyzanski SJ, Jenkins CD, Ryan TJ, Flessas A, Everist M: Psychological correlates of coronary angiographic findings. Arch Intern Med 1976;136: 1234-1237.
93. Matthews KA: Psychological perspectives on the type A behavior pattern. Psychol Bull 1982;9: 293-323.
94. Jenkins CD, Zyzanski SJ, Rosenman RH: Progress toward validation of a computer-scored test for the type A coronary-prone behavior pattern. Psychosom Med 1971;33: 193-202.
95. Blumenthal JA, Herman S, O'Toole LC, Haney TL, Williams RB Jr, Barefoot JC: Development of a brief self-report measure of the type A (coronary prone) behavior pattern. J Psychosom Res 1985;29: 265-274.
96. Chesney MA, Black GW, Chadwick JH, Rosenman RH: Psychological correlates of the type A behavior pattern. J Behav Med 1981;4: 217-229.
97. Young LD, Barboriak JJ: Reliability of a brief scale for assessment of coronary-prone behavior and standard measures of type A behavior. Percept Mot Skills 1982;55: 1039-1042.
98. Almada SJ, Zonderman AB, Shekelle RB, Dyer AR, Daviglus ML, Costa PT Jr, Stamler J: Neuroticism and cynicism and risk of death in middle aged men: the Western Electric Study. Psychosom Med 1991; 53: 165-175.
99. Cook W, Medley D: Proposed hostility and pharasaic- virtue scales for the MMPI. J Appl Psychol 1954; 38: 414-418.
100. Barefoot JC, Larsen S, von der Lieth L, Schroll M: Hostility, incidence of acute myocardial infarction, and mortality in a sample of older Danish men and women. Am J Epidemiol 1995;142: 477-484.
101. Sallis JF, Johnson CC, Trevorrow TR, Kaplan RM, Hovell MF: The relationship between cynical hostility and blood pressure reactivity. J Psychosom Res 1987;31: 111-116.
102. Megargee E: The dynamics of aggression and their application to cardiovascular disorders; in Chesney M, Rosenman R (eds): Anger and Hostility in Cardiovascular and Behavioral Disorders. New York, Hemisphere/McGraw Hill, 1985, pp 31-57.
103. Costa PT, Zonderman AB, McCrae RR, Williams RB: Cynicism and paranoid alienation in the Cook and Medley HO Scale. Psychosom Med 1986;48: 283-285.
104. Barefoot JC, Dodge KA, Peterson BL, Dahlstrom WG, Williams RB: The Cook-Medley hostility scale: item content and ability to predict survival. Psychosom Med 1989;51: 46-57.
105. Barefoot JC, Lipkus IM: The assessment of anger and hostility; in Siegman AW, Smith TW (eds): Anger, Hostility, and the Heart. Hillsdale: Lawrence Erlbaum Associates, 1994, pp 43-66.
106. Georgiades A, Lane JD, Boyle SH, Brummett BH, Barefoot JC, Kuhn CM, Feinglos MN, Williams RB, Merwin R, Minda S, Siegler IC, Surwit RS: Hostility and fasting glucose in African American women. Psychosom Med 2009;71: 642-645.
107. Siegler IC, Zonderman AB, Barefoot JC, Williams RB Jr, Costa PT Jr, McCrae RR: Predicting personality in adulthood from college MMPI scores: implications for follow-up studies in psychosomatic medicine. Psychosom Med 1990;52: 644-652.
108. Smith TW: Hostility and health: current status of a psychosomatic hypothesis. Health Psychol 1992;11: 139-150.
109. Denollet J, Sys SU, Brutsaert DL: Personality and mortality after myocardial infarction. Psychosom Med 1995;57: 582-591.
110. Denollet J: Biobehavioral research on coronary heart disease: where is the person? J Behav Med 1993;16: 115-141.
111. Kupper N, Denollet J: Type-D personality as a prognostic factor in heart disease: assessment and mediating mechanisms. J Pers Assess 2007;89: 265-276.
112. Aquarius AE, Denollet J, Hamming JF, De Vries J: Role of disease status and Type D personality in outcomes in patients with peripheral arterial disease. Am J Cardiology 2005;96: 996-1001.
113. Denollet J: Personality and risk of cancer in men with coronary heart disease. Psychol Med 1998;28: 991-995.
114. Denollet J, Vaes J, Brutsaert DL: Inadequate response to treatment in coronary heart disease: adverse effects of Type D personality and younger age on 5-year prognosis and quality of life. Circulation 2000;102: 630-635.
115. Denollet J, Schiffer AA, Spek V: A general propensity to psychological distress affects cardiovascular outcomes. Evidence from research on the type D (distressed) personality profile. Circ Cardiovasc Qual Outcomes 2010;3: 546-557.
116. Pedersen SS, Lemos PA, van Vooren PR, Liu TK, Daemen J, Erdman RA, Smits PC, Serruys PW, van Dombrug RT: Type D personality predicts death or myocardial infarction after bare metal stent or sirolimuseluting stent implantation: a Rapamycin- Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry sub-study. J Am Coll Cardiol 2004;44: 997-1001.
117. Pedersen SS, Denollet J: Validity of the Type D personality construct in Danish post-MI patients and healthy controls. J Psychosom Res 2004;57: 265-272.
118. Pedersen SS, Middel B: Increased vital exhaustion among Type D patients with ischemic heart disease. J Psychosom Res 2001;51: 443-449.
119. Habra ME, Linden W, Anderson JC, Weinberg J: Type D personality is related to cardiovascular and neuroendocrine reactivity to acute stress. J Psychosom Res 2003;55: 235-245.
120. Ketterer MW, Denollet J, Chapp J, Thayer B, Keteyian S, Clark V, John S, Farha AJ, Deveshwar S: Men deny and women cry, but who dies? Do the wages of 'denial' include early ischemic coronary heart disease? J Psychosom Res 2004;56: 119-123.
121. Denollet J: Personality and coronary heart disease: the Type D Scale-16 (DS16). Ann Behav Med 1998; 20: 209-215.
122. De Fruyt F, Denollet J: Type D personality: a fivefactor model perspective. Psychol Health 2002;17: 671-683.
123. Ketterer MW, Denollet J, Goldberg AD, McCullough PA, John S, Farha AJ, Clark V, Keteyian S, Chapp J, Thayer B, Deveshwar S: The big mush: psychometric measures are confounded and non-independent in their association with age at initial diagnosis of ischemic coronary heart disease. J Cardiovasc Risk 2002;9: 41-48.
124. Pedersen SS, van Domburg RT, Theuns DA, Jordaens L, Erdman RA: Type D personality is associated with increased anxiety and depressive symptoms in patients with an implantable cardioverter defibrillator and their partners. Psychosom Med 2004;66: 714-719.
125. Butcher JN, Dahlstrom WG, Graham JR, Tellegen A, Kaemmer B: MMPI-2: Minnesota Multiphasic Personality Inventory-2: Manual for Administration and Scoring. Minneapolis, University of Minnesota Press, 1989.
126. Denollet J: DS14: Standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosom Med 2005;67: 89-97.
127. Denollet J: Type D personality: a potential risk factor refined. J Psychosom Res 2000;49: 255-266.
128. Cloninger CR, Svrakic DM, Przybeck TR: A psychobiological model of temperament and character. Arch Gen Psychiatry 1993;50: 975-990.
129. Cloninger CR, Przybeck TR, Svrakic DM, Wetzel RD: The Temperament and Character Inventory (TCI): A Guide to Its Development and Use. St. Louis, Washington University Center for Psychobiology of Personality, 1994.
130. Cloninger CR, Przybeck TR, Svrakic DM: The Tridimensional Personality Questionnaire: U.S. normative data. Psychol Rep 1991;69: 1047-1057.
131. Sonino N, Bonnini S, Fallo F, Boscaro M, Fava GA: Personality characteristics and quality of life in patients treated for Cushing's syndrome. Clin Endocrinol (Oxf) 2006;64: 314-318.
132. Richter J, Eismann M, Richter G, Cloninger CR: Das Temperament und Charakter Inventar (TCI: ein Leitfaden uber seine Entwicklung und Anwendung). Gottingen, Swets Test Services, 1999.
133. Gana K, Trouillet R: Structure invariance of the Temperament and Character Inventory. Pers Individ Dif 2003;34: 1-13.
134. Tomita T, Aoyama H, Kitamura T, Sekiguchi C, Murai T, Matsuda T: Factor structure of psychobiological seven-factor model of personality: a modelrevision. Pers Individ Dif 2000;29: 709-727.
135. Pelissolo A, Andre C, Pujol H, Yao SN, Servant D, Braconnier A, Orain-Pelissolo S, Bouchez S, Lepine JP: Personality dimensions in social phobics with or without depression. Acta Psychiatr Scand 2002;105: 94-103.
136. Miettunen J, Kantojarvi L, Ekelund J, Veijola J, Karvonen JT, Peltonen L, Jarvelin MR, Freimer N, Lichtermann D, Joukamaa M: A large population cohort provides normative data for investigation of temperament. Acta Psychiatr Scand 2004;110: 150-157.
137. Sellman JD, Mulder RT, Sullivan PF, Joyce PR: Low persistence predicts relapse in alcohol dependence following treatment. J Stud Alcohol 1997;58: 257-263.
138. Nylander PO, Schlette P, Brandstrom S, Nilsson M, Forsgren T, Forsgren TL, Adolfsson R: Migraine: temperament and character. J Psychiatr Res 1996;30: 359-368.
139. Boz C, Velioglu S, Ozmenoglu M, Sayar K, Alioglu Z, Yalman B, Topbas M: Temperament and character profiles of patients with tension-type headache and migraine. Psychiatry Clin Neurosci 2004;58: 536-543.
140. Kim TS, Pae CU, Jeong JT, Kim SD, Chung KI, Lee C: Temperament and character dimensions in patients with atopic dermatitis. J Dermatol 2006;33: 10-15.
141. Cloninger CR: A systematic method for clinical description and classification of personality variants; a proposal. Arch Gen Psychiatry 1987;44: 573-588.
142. Forrest S, Dunn K, Elliott K, Fitzpatrick E, Fullerton J, McCarthy M, Brown J, Hill D, Williamson R: Identifying genes predisposing to atopic eczema. J Allergy Clin Immunol 1999;104: 1066-1070.
143. Kilic A, Gulec MY, Gul U, Gulec H: Temperament and character profile of patients with psoriasis. J Eur Acad Dermatol Venereol 2008;22: 537-542.
144. McCrae RR, Costa PT Jr: Updating Norman's 'Adequate Taxonomy': intelligence and personality dimensions in natural language and in questionnaires. J Pers Soc Psychol 1985;49: 710-721.
145. McCrae RR, Costa PT: Personality in Adulthood: A Five-Factor Theory Perspective, ed 2. New York, Guilford Press, 2003.
146. Goldberg LR: Language and individual differences: the search for universals in personality lexicons; in Wheeler L (ed): Review of Personality and Social Psychology. Beverly Hills, Sage, 1981, vol 2, pp 141-165.
147. Costa PT Jr, McCrae RR: Revised NEO Personality Inventory (NEO-PI-R) and NEO Five-Factor Inventory (NEO-FFI) professional manual. Odessa, Psychological Assessment Resources, 1992.
148. McCrae RR: The Five-Factor Model and its assessment in clinical settings. J Pers Assess 1991;57: 399-414.
149. Eysenck HJ, Eysenck SBG: Manual of the Eysenck Personality Questionnaire. San Diego, EdITS, 1975.
150. Guilford JS, Zimmerman WS, Guilford JP: The Guilford-Zimmerman Temperament Survey Handbook: Twenty-Five Years of Research and Application. San Diego, EdITS, 1976.
151. Gough HG: California Psychological Inventory Administrator's Guide. Palo Alto, Consulting Psychologists Press, 1987.
152. Jackson DN: Personality Research from manual, ed 3. Port Huron, Research Psychologists Press, 1984.
153. Myers IB, McCaulley MH: Manual: a guide to the development and use of the Myers-Briggs Type Indicator. Palo Alto, Consulting Psychologists Press, 1985.
154. Morey LC: Personality Assessment Inventory. Odessa, Psychological Assessment Resources, 1991.
155. McCrae RR, Costa PT Jr, Dahlstrom WG, Barefoot JC, Siegler IC, Williams RB Jr: A caution on the use of the MMPI K-correction in research on psychosomatic medicine. Psychosom Med 1989;51: 58-65.
156. Tanum L, Malt UF: Personality and physical symptoms in non psychiatric patients with functional gastrointestinal disorder. J Psychosom Res 2001;50: 139-146.
157. Nater UM, Jones JF, Lin JM, Maloney E, Reeves WC, Heim C: Personality features and personality disorders in chronic fatigue syndrome: a population- based study. Psychother Psychosom 2010;79: 312-318.
158. Christensen AJ, Ehlers SL, Wiebe JS, Moran PJ, Raichle KA, Ferneyhough K, Lawton WJ: Patient personality and mortality: a 4-year prospective examination of chronic renal insufficiency. Health Psychol 2002;21: 315-320.
159. Weiss A, Costa PT Jr: Domain and facet personality predictors of all-cause mortality among Medicare patients aged 65 to 100. Psychosom Med 2005;67: 724-733.
160. Jonassaint CR, Boyle SH, Williams RB, Mark DB, Siegler IC, Barefoot JC: Facets of openness predict mortality in patients with cardiac disease. Psychosom Med 2007;69: 319-322.
161. Taylor MD, Whiteman MC, Fowkes GR, Lee AJ, Allerhand M, Deary IJ: Five Factor Model personality traits and all-cause mortality in the Edinburgh Artery Study cohort. Psychosom Med 2009;71: 631-641.
162. Sutin AR, Terracciano A, Deiana B, Uda M, Schlessinger D, Lakatta EG, Costa PT Jr: Cholesterol, triglycerides, and the Five-Factor Model of personality. Biol Psychol 2010;84: 186-191.
163. Fava GA: The concept of recovery in affective disorders. Psychother Psychosom 1996;65: 2-13.
164. Fava GA, Ruini C, Rafanelli C: Psychometric theory is an obstacle to the progress of clinical research. Psychother Psychosom 2004;73: 145-148.
165. Fava GA: The intellectual crisis of psychiatric research. Psychother Psychosom 2006;75: 202-208.
166. Reich J: State and trait in personality disorders. Ann Clin Psychiatry 2007;19: 37-44.
167. Ryan RM, Deci EL: On happiness and human potential: a review of research on hedonic and eudaimonic well-being. Annu Rev Psychol 2001;52: 141-166.
168. Fava GA, Tomba E: Increasing psychological wellbeing and resilience by psychotherapeutic methods. J Pers 2009;77: 1903-1934.
169. Levant RF: Desperately seeking language: Understanding, assessing, and treating normative male alexithymia; in Brooks GR, Good GE (eds): The new handbook of psychotherapy and counseling with men: A comprehensive guide to settings, problems, and treatment approaches. San Francisco, Jossey-Bass/Pfeiffer, 2001, pp 424-443.
170. Fava GA, Tomba E: New modalities of assessment and treatment planning in depression: the sequential approach. CNS Drugs 2010;24: 453-465.
171. Weinrich SP, Weinrich MC, Keil JE, Gazes PC, Potter E. The John Henryism and Framingham Type A Scales. Measurement properties in elderly blacks and whites. Am J Epidemiol 1988;128: 165-178.
172. Butcher JN, Graham JR, Ben-Porath YS, Tellegen A, Dahlstrom WG, Kaemmer B. Minnesota Multiphasic Personality Inventory-2: Manual for administration, scoring, and interpretation (rev. ed.). Minnesota, University of Minnesota Press, 2001.